Press Releases
CLSI is your source for laboratory standards news and information.
Find important updates, industry news, and information on CLSI’s upcoming events. Check out our past press releases, upcoming Committees Week, and newsworthy items.
January 26, 2018
Wayne, Pennsylvania, USA—January 2018—CLSI Excellence Awards are bestowed upon volunteers who are committed to CLSI’s mission. Recipients are recognized for dedicating significant time and effort to the development, implementation, and promotion of voluntary consensus standards. The recipients are nominated by their peers and selected by the CLSI Awards Committee. CLSI celebrates the achievements of volunteers, as they are fundamental to the development of best practices in clinical and laboratory testing.
Read More
January 16, 2018
The Clinical and Laboratory Standards Institute announces the publication of its annually updated antimicrobial susceptibility testing (AST) supplement M100—Performance Standards for Antimicrobial Susceptibility Testing, 28th ed., as well as its associated methodology standards M02—Performance Standards for Antimicrobial Disk Susceptibility, 13th ed. And M07—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 11th ed. This year M100 is available as part of a package with either M02 or M07, or all three documents together.
Read More
December 14, 2017
The US Food & Drug Administration (FDA) has taken an important step to improve public health by creating a website to make critical updates regarding antimicrobial drugs available to health care professionals. This information helps laboratories report the most current information to health care providers about what type of infection a patient has and what the most effective treatment will be. The website provides information on the most up-to-date Susceptibility Test Interpretive Criteria (STIC), also known as breakpoints. Breakpoints help determine whether a specific bacteria or fungi are susceptible to (ie, will respond to treatment with) antibacterial or antifungal drugs. According to the FDA, “This approach is intended to aid health care professionals in making more informed prescribing decisions that will both benefit their patients and prevent the spread of resistant bacteria.”
Read More
December 4, 2017
The Clinical and Laboratory Standards Institute has published four antifungal Microbiology documents:
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts (M27-Ed4),
Performance Standards for Antifungal Susceptibility Testing of Yeasts (M60-Ed1),
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi (M38-Ed3), and Performance Standards for Antifungal Susceptibility Testing of Filamentous Fungi (M61-Ed1).
Read More
September 29, 2017
QMS19 provides information on how laboratories can develop and maintain a customer focus and meet the regulatory and accreditation requirements for managing external and internal customers. The document is intended to assist laboratories in meeting customer-based requirements for their quality management system (QMS).
Read More
September 5, 2017
The Clinical and Laboratory Standards Institute (CLSI) and the US Department of Health and Human Services’ Centers for Disease Control and Prevention (CDC) are entering the fifth year of a cooperative agreement intended to increase effectiveness and adoption of model laboratory practice guidelines. A laboratory practice guideline is a written recommendation for voluntary, standardized approaches for medical laboratory testing.
Read More
August 31, 2017
The Clinical and Laboratory Standards Institute announces the publication of External Assessments, Audits, and Inspections of the Laboratory (QMS17).
Read More
July 31, 2017
The Clinical and Laboratory Standards Institute announces the publication of Developing and Managing a Medical Laboratory (Test) Utilization Program (GP49-Ed1).
Read More
May 31, 2017
The Clinical and Laboratory Standards Institute has published two newborn screening documents: Newborn Screening by Tandem Mass Spectrometry (NBS04-Ed2), and Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid a-Glucosidase Activity Assays (NBS07-Ed1).
Read More
May 26, 2017
The Clinical and Laboratory Standards Institute has published the toxicology and chemistry guideline Toxicology and Drug Testing in the Medical Laboratory (C52-Ed3).
Read More
